Effects of Teriparatide in Postmenopausal Women With Osteoporosis

NCT00079924 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: teriparatide
DRUG: aldrenodate
DRUG: raloxifene

Sponsor

Eli Lilly and Company